Form 4: Verrica Pharmaceuticals CEO Buys Shares
Insider Transaction (Form 4)
Jayson Rieger, CEO and President and a Director of Verrica Pharmaceuticals Inc., purchased 25,000 shares of common stock on August 14, 2026.
Summary
- Open-market purchase: acquired 20,000 Common Stock at $5.06 ($101,200) on August 14, 2026; holds 202,593 after (Direct).
- Open-market purchase: acquired 5,000 Common Stock at $4.91 ($24,550) on August 17, 2026; holds 207,593 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $125,750, committing personal capital to the stock.
Insider Transactions
Jayson Rieger — Director, Officer (CEO and President)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Open-market purchase | Common Stock | 20,000 | $5 | $101.2K | 202,593 |
| 2026-08-17 | Open-market purchase | Common Stock | 5,000 | $5 | $24.6K | 207,593 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Open-market purchase (20,000 shares) |
| 2026-08-17 | Open-market purchase (5,000 shares) |
Keywords
insider transaction, Form 4, VRCA, Verrica Pharmaceuticals Inc., bullish, Jayson Rieger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.